← All .science files
pmid:35187044
CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression.
Yong Xiao · Kun Yang · Zhen Wang · Mengjie Zhao · Yanxiang Deng · Wei Ji · Yuanjie Zou · Chunfa Qian · Yong Liu · Hong Xiao · Hongyi Liu
Frontiers in surgery · 2021 doi:10.3389/fsurg.2021.775194
Paper
complete
Experiment
complete
Data
partial
Analysis
complete
Execution
absent
Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
paper object · 10 fields
authors array · 11 items
claims array · 3 items
[0] object · 6 fields
evidence array · 1 item
[0] object · 3 fields
[1] object · 6 fields
evidence array · 1 item
[0] object · 3 fields
gaps array · 0 items
experiment object · 8 fields
steps array · 3 items
[0] object · 13 fields
parameters object · 0 fields
inputs array · 1 item
outputs array · 1 item
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
parameters object · 0 fields
inputs array · 1 item
outputs array · 1 item
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
parameters object · 0 fields
inputs array · 1 item
outputs array · 1 item
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
assets array · 3 items
[0] object · 15 fields
structure object · 4 fields
[1] object · 15 fields
structure object · 15 fields
sample_accessions array · 8 items
[2] object · 15 fields
structure object · 15 fields
sample_accessions array · 29 items
gaps array · 4 items
analysis object · 4 fields
methods array · 3 items
[0] object · 10 fields
dsl_operations array · 1 item
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
evidence object · 3 fields
[1] object · 10 fields
dsl_operations array · 1 item
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[2] object · 10 fields
dsl_operations array · 1 item
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
requirements array · 1 item
[0] object · 6 fields
assay_families array · 9 items
gaps array · 0 items
readiness object · 8 fields
axes object · 3 fields
method object · 5 fields
required_operations array · 1 item
missing_operations array · 0 items
capability object · 4 fields
data object · 6 fields
accessions array · 2 items
resolved_accessions array · 2 items
statements array · 1 item
can_run object · 3 fields
dsl_operations array · 1 item
assets array · 2 items
steps array · 1 item
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
gaps array · 0 items
review object · 5 fields
machine_critique object · 5 fields
reader object · 5 fields
evidence_check object · 2 fields
usage object · 3 fields
stages array · 1 item
[0] object · 4 fields
gaps array · 3 items
provenance object · 7 fields
entities array · 3 items
activities array · 3 items
[0] object · 4 fields
used array · 3 items
[0] object · 3 fields
[1] object · 3 fields
[2] object · 3 fields
[1] object · 4 fields
agents array · 2 items
lineage object · 4 fields
gaps array · 8 items
assays array · 2 items
[0] object · 11 fields
required_operations array · 0 items
source_hashes object · 1 field
evidence array · 4 items
[1] object · 11 fields
required_operations array · 1 item
source_hashes object · 1 field
evidence array · 1 item
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:35187044", "kind": "science-record", "revision": 5, "content_hash": "sha256:38ef21178018406a53c57c7d197b1d577c3e2aa66ea6dbe03585fbbd3fc5f2f3", "created_at": "2026-11-01T17:36:57Z", "updated_at": "2026-11-01T22:48:32Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "CD44-Mediated Poor Prognosis in Glioma Is Associated With M2-Polarization of Tumor-Associated Macrophages and Immunosuppression.", "doi": "10.3389/fsurg.2021.775194", "pmid": "35187044", "authors": ["Yong Xiao", "Kun Yang", "Zhen Wang", "Mengjie Zhao", "Yanxiang Deng", "Wei Ji", "Yuanjie Zou", "Chunfa Qian", "Yong Liu", "Hong Xiao", "Hongyi Liu"], "journal": "Frontiers in surgery", "year": 2021, "abstract": "BACKGROUND: Glioma is the most common primary brain tumor with a poor prognosis. Key genes that are negatively related to prognosis may provide the therapy targets to cure glioma. To clarify the role of CD44 in glioma, we explored its function at bulk-transcriptome, spatial and single-cell transcriptome levels.\nMETHODS: In total, expression profiles with survival data of whole-grade glioma from The Cancer Genome Atlas (TCGA) and the Chinese Glioma Genome Atlas (CGGA), RNA-seq data with anatomic information of glioblastoma (GBM) from the Ivy Glioblastoma Atlas Project, RNA-sequencing (RNA-seq) data from recurrent GBM receiving adjuvant anti-PD-1 immunotherapy accessed through GSE121810, and single-cell RNA-seq data of GBM under accession GSE103224 were enrolled in this study. CD44-specific findings were further analyzed by R language.\nRESULTS: CD44 is positively correlated with WHO grade of malignancy and is negatively related to prognosis in glioma. Meanwhile, CD44 predominantly expresses in GBM mesenchymal subtype, and gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses reveal that CD44 positively coexpressed genes are closely related to glioma immunity. Moreover, CD44+ cells mainly distribute in perinecrotic region with high expression of immune factors. At single-cell resolution, only malignant tumor cells, tumor-associated macrophages (TAMs), and T cells express CD44 in GBM. CD44+ malignant tumor cells are in mesenchymal-1-like (MES1-like) cellular state, and CD44+ TAMs are in M2 phenotype. CD44+ T cells have high expression of both PD-1 and PD-L1. CD44 and its directly interacted inhibitory immunomodulators are upregulated in patients with nonresponder recurrent GBM treated with PD-1 blockade therapy.\nCONCLUSION: Our work demonstrates that CD44, a new M2 TAM biomarker, is involved in immune suppressor and promote glioma progression in glioma microenvironment. These results expand our understanding of CD44-specific clinical and immune features in glioma.", "claims": [{"id": "claim-method", "statement": "Survival curves were performed by Kaplan–Meier analysis between CD44 higher and lower group and were tested for significance using the Mantel–Cox log-rank test. Hazard ratio (HR) and confidence interval (CI) were also computed to confirm the prognostic value of CD44 in patients with glioma. Furthermore, Cox proportional hazards model, including patients' age and gender, was used to evaluate the predictor effect of CD44.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35187044", "locator": "sections[4] \"Survival Analysis\" paragraph 2", "quote": "Survival curves were performed by Kaplan–Meier analysis between CD44 higher and lower group and were tested for significance using the Mantel–Cox log-rank test. Hazard ratio (HR) and confidence interval (CI) were also computed to confirm the prognostic value of CD44 in patients with glioma. Furthermore, Cox proportional hazards model, including patients' age and gender, was used to evaluate the predictor effect of CD44."}], "state": "complete"}, {"id": "claim-data-access", "statement": "Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:35187044", "locator": "sections[23] \"Data Availability Statement\" paragraph 2", "quote": "Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224."}], "state": "complete"}, {"id": "claim-target-result", "statement": "CD44 is positively correlated with WHO grade of malignancy and is negatively related to prognosis in glioma.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:35187044", "locator": "sections[0] \"Abstract\" paragraph 3", "quote": "CD44 is positively correlated with WHO grade of malignancy and is negatively related to prognosis in glioma."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": "CD44 is positively correlated with WHO grade of malignancy and is negatively related to prognosis in glioma.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:35187044"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE103224"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE103224"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:35187044", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3389/fsurg.2021.775194", "sha256": "sha256:2ee89a08127301e2c85f5696c6b16f069d5a43598185f6335ba60d2e1e6c46b2", "bytes": 63509, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3389/fsurg.2021.775194", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC8850306", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE103224", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE103224", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE103224", "version": null, "note": "Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM2758471", "GSM2758472", "GSM2758473", "GSM2758474", "GSM2758475", "GSM2758476", "GSM2758477", "GSM2940098"], "sample_count": 8, "group_sizes": null, "group_sizes_basis": null, "platform": "18573", "taxon": "Homo sapiens", "title": "Single-Cell Transcriptome Analysis of Lineage Diversity and Microenvironment in High-Grade Glioma", "resolution_checked_at": "2026-11-01T18:06:43Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE121810", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE121810", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE121810", "version": null, "note": "Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM3447008", "GSM3447009", "GSM3447010", "GSM3447011", "GSM3447012", "GSM3447013", "GSM3447014", "GSM3447015", "GSM3447016", "GSM3447017", "GSM3447018", "GSM3447019", "GSM3447020", "GSM3447021", "GSM3447022", "GSM3447023", "GSM3447024", "GSM3447025", "GSM3447026", "GSM3447027", "GSM3447028", "GSM3447029", "GSM3447030", "GSM3447031", "GSM3447032", "GSM3447033", "GSM3447034", "GSM3447035", "GSM3447036"], "sample_count": 29, "group_sizes": null, "group_sizes_basis": null, "platform": "21290", "taxon": "Homo sapiens", "title": "Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma", "resolution_checked_at": "2026-11-01T18:06:43Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE103224 not downloaded", "asset:data:geo:GSE103224 licence not read", "asset:data:geo:GSE121810 not downloaded", "asset:data:geo:GSE121810 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Survival curves were performed by Kaplan–Meier analysis between CD44 higher and lower group and were tested for significance using the Mantel–Cox log-rank test. Hazard ratio (HR) and confidence interval (CI) were also computed to confirm the prognostic value of CD44 in patients with glioma. Furthermore, Cox proportional hazards model, including patients' age and gender, was used to evaluate the predictor effect of CD44."}}, {"id": "method-2", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "log-rank"}}, {"id": "method-3", "family": "correlation_analysis", "specific": "pearson", "label": "Correlation analysis", "dsl_operations": ["pearson_r"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["paired_numeric_columns"], "evidence": {"score": 0.8, "band": "high", "quote": "Pearson's correlation"}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE121810", "GSE103224"], "resolved_accessions": ["GSE121810", "GSE103224"], "statements": ["Publicly available datasets were analyzed in this study. These data can be found at: TCGA database (https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga), the CGGA database (http://www.cgga.org.cn/), the IGAP database (http://glioblastoma.alleninstitute.org/), and the GEO database (https://www.ncbi.nlm.nih.gov/geo) with accession number GSE121810 and GSE103224."], "basis": "The paper names GSE121810, GSE103224 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:35187044", "data:geo:GSE103224"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE103224"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T17:35:15Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 17856, "completion_tokens": 1770, "cached_tokens": 128}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:35187044", "type": "paper", "label": "pmid:35187044"}, {"id": "source:pmid:35187044", "type": "manuscript", "label": "PMID 35187044 full text"}, {"id": "data:geo:GSE103224", "type": "dataset", "label": "GEO GSE103224"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:35187044", "type": "paper", "label": "pmid:35187044"}, {"id": "source:pmid:35187044", "type": "manuscript", "label": "PMID 35187044 full text"}, {"id": "data:geo:GSE103224", "type": "dataset", "label": "GEO GSE103224"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-35187044", "type": "extraction", "used": ["source:pmid:35187044"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE103224", "type": "accession_resolution", "used": ["data:geo:GSE103224"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:35187044", "parent_hash": "sha256:f78f4e1897f362397398c44adef5c3ace1c7550d0e6bc23aec4540d301e69a5b", "fork_of": null, "generation": 4}, "gaps": ["asset:data:geo:GSE103224 licence not read", "asset:data:geo:GSE103224 not downloaded", "asset:data:geo:GSE121810 licence not read", "asset:data:geo:GSE121810 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "rna_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["and the Chinese Glioma Genome Atlas (CGGA), RNA-seq data with anatomic information of glioblasto", "accessed through GSE121810, and single-cell RNA-seq data of GBM under accession GSE103224 were e", "BM) from the Ivy Glioblastoma Atlas Project, RNA-sequencing (RNA-seq) data from recurrent GBM receiving", "Glioblastoma Atlas Project, RNA-sequencing (RNA-seq) data from recurrent GBM receiving adjuvant"], "order_basis": "paper_text_order:337", "id": "assay:1"}, {"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Survival curves were performed by Kaplan–Meier analysis between CD44 higher and lower group and were tested for significance using the Mantel–Cox log-rank test. Hazard ratio (HR) and confidence interval (CI) were also computed to confirm the prognostic value of CD44 in patients with glioma. Furthermore, Cox proportional hazards model, including patients' age and gender, was used to evaluate the predictor effect of CD44."], "order_basis": "consumes_earlier_output", "id": "assay:2"}]}